Portfolio data

Browse all portfolio data news

    Latest portfolio data news

    Show news from

    Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease

    Resolution Therapeutics Announces Regenerative Macrophage Therapy (RMT) Manufacturing Process & Candidate Testing Suite at ASGCT 2025

    iOnctura commences randomised Phase I/II study in non-small cell lung cancer

    iOnctura commences randomized Phase II study in metastatic uveal melanoma

    iOnctura reaches new clinical milestones in uveal melanoma

    Quell Therapeutics to Present Promising Data from Autologous and Allogenic CAR-Treg Programs at Upcoming International Congresses

    Load more

    Search